SCHD ETF is doing something many income investors did not expect in a market shaped by elevated Treasury yields and artificial intelligence-driven equity leadership. The fund has reached about $101.11 billion in assets while posting a 26.51% total return over the past 12 months, outpacing the S&P 500 by roughly six percentage points.
That result stands out because SCHD’s yield, around 3.06% at a share price of $32.89, remains below the 10-year Treasury yield of 4.628%. In simple income terms, that gap should have been a headwind. Instead, dividend growth, capital appreciation, and a timely portfolio rotation have combined to lift the fund to a 52-week high.
For investors, the key question is no longer whether SCHD can deliver income. It is whether the ETF can sustain its relative strength as interest-rate expectations, sector leadership, and defensive positioning continue to shift through the second half of 2026.
Key Facts
- SCHD traded at $32.89, near its 52-week high of $32.91, after rising 25.7% from its $26.16 low.
- The fund has approximately $101.11 billion in assets under management and recorded about $15.35 billion in net inflows over the trailing 12 months.
- SCHD delivered a 26.51% 12-month total return and a 23.36% year-to-date total return through July 24.
- The ETF pays a quarterly distribution of $0.257, or roughly $1.05 over the trailing 12 months, for a yield between 3.06% and 3.3% depending on price.
- The expense ratio is 0.06%, and the fund has increased payouts annually for 14 consecutive years, with a 15th increase on pace in 2026.
SCHD ETF
SCHD’s recent performance matters because it breaks the usual script for dividend strategies. A fund yielding just over 3% would normally struggle when the risk-free rate on a 10-year Treasury sits above 4.6%. Yet SCHD is not behaving like a bond substitute. It is functioning as a quality-focused equity vehicle whose dividend stream is growing, while its holdings have also benefited from a rotation toward profitable, cash-generating companies.
The fund’s methodology helps explain the result. SCHD screens for companies with at least a 10-year dividend history, then ranks them using free cash flow to debt, return on equity, dividend yield, and five-year dividend growth. That framework tends to exclude speculative high-yield names and many newer growth stocks, while favoring established large-cap businesses with stronger balance sheets. In a year marked by volatility in semiconductors and shifting expectations for the Federal Reserve, that profile has looked increasingly attractive.
The March 2026 reconstitution also played a significant role. The portfolio added 25 companies and removed 22, cutting energy exposure by roughly eight percentage points after the sector had become a major driver of prior gains. It also brought in new large positions such as UnitedHealth, Abbott Laboratories, Procter & Gamble, Qualcomm, Accenture, Comcast, and Automatic Data Processing. The result is a more defensive portfolio, with healthcare now occupying the top four positions and the fund holding 103 stocks overall.
“SCHD’s edge in 2026 has come from total return, not headline yield, proving that dividend growth and disciplined sector rotation can still outperform in a high-rate market.”
Why SCHD Has Outperformed Despite Higher Treasury Yields
The most important distinction is between current yield and total return. A Treasury bond offers a fixed coupon, but SCHD’s payouts have risen every year since inception on October 20, 2011. If the distribution continues to grow, an investor’s yield on original cost can increase over time, unlike a static bond coupon. That income growth becomes more powerful when reinvested.
Price appreciation has mattered just as much. Over the past year, SCHD’s income stream was supplemented by strong gains in defensive sectors and a successful rebalance away from areas that had already surged. Since inception, the ETF has delivered a nominal total return of 537.62%, compounding at 13.37% annually. That long-run record reinforces the idea that SCHD should be viewed as an equity strategy with an income component, not as a simple alternative to fixed income.
Implications for Investors
For portfolio construction, SCHD remains relevant because it sits between pure growth and pure income. Its yield is meaningfully above the broader equity market, but it avoids the extreme payout profiles and option-based strategies that can cap upside or introduce additional complexity. The combination of low cost, dividend growth, and quality screens makes it a useful core holding for investors seeking defensive equity exposure.
At the same time, risks are becoming more visible. The ETF’s top 10 holdings account for about 41.19% of assets, creating notable concentration. UnitedHealth alone represents 4.49%, and healthcare has become the dominant leadership group within the portfolio. That defensive tilt can help during economic uncertainty, but it also increases sensitivity to regulatory changes, reimbursement policy shifts, and sector-specific political pressure.
Interest rates remain the biggest near-term watch point. With the 10-year Treasury at 4.628% and the 2-year at 4.306%, SCHD still competes against higher current income from government bonds. If the Federal Reserve signals tighter policy or if long-term yields move closer to 5%, valuation pressure could build on dividend-oriented equities. Conversely, if inflation continues to cool and rate expectations soften, SCHD’s blend of yield and quality could remain attractive relative to both broad equities and fixed income.
The fund also appears well positioned if the market rotation away from expensive AI-linked names continues. Holdings tied to healthcare, consumer staples, industrials, and mature cash-generating businesses are less exposed to semiconductor cycles and capital-spending slowdowns. That does not mean SCHD will lead in every rally, but it does suggest resilience if leadership broadens beyond mega-cap technology.
Investors watching SCHD in the coming months should focus on three variables: Treasury yields, earnings resilience across its top holdings, and whether fund inflows remain strong after surpassing the $100 billion mark. If those supports hold, SCHD could continue to justify its premium position in the dividend ETF market.
The next phase for SCHD will depend less on its past outperformance and more on whether dividend growth can keep offsetting rate pressure. For now, the ETF has shown that in 2026, disciplined quality and rising income still have a place in a market dominated by big macro shifts.